The MDIBL center for comparative biology of tissue repair, regeneration and aging - overall project summary limited regeneration of damaged organs and tissues in humans leads to chronic disease and…

Active Grant Awarded Last action

Award ID
P30GM154610
Recipient
Awarding agency
Obligated
$3,771,493

Award facts

Assistance listing
93.859 Biomedical Research and Research Training
Completion date 48% complete
Place of performance
Salsbury Cove, ME 04672, USA

Award details come from USAspending.gov.

Description

The MDIBL center for comparative biology of tissue repair, regeneration and aging - overall project summary limited regeneration of damaged organs and tissues in humans leads to chronic disease and degeneration, while in many invertebrates and lower vertebrates, cellular regeneration repairs and preserves tissue function throughout the lifespan. Cobre phases I and II comparative biology of tissue repair, regeneration and aging, played a central role in establishing the kathryn W. Davis center for regenerative biology and aging (davis center) at the MDI biological laboratory (MDIBL) as a leading institute in comparative biology. The davis center was founded on the principle that comparative studies of diverse animal models would lead to a mechanistic understanding of tissue and organ regeneration and identify key points of intervention to improve regeneration in human tissues. In addition, davis center research has focused on mechanisms of aging using multiple organisms to learn how cellular anabolic and catabolic pathways may be linked to extension of healthspan. Comparative studies such as these provide a screening platform and rational foundation for development of regenerative medicine therapies, including small molecule drug candidates capable of stimulating tissue regeneration and slowing or reversing aging-induced degenerative changes in patients. Cobre phases I and II supported eight early-career project leaders and one mid-career project leader. Six project leaders graduated with major independent grant support and the most recent cobre recruit, prayag murawala, has achieved significant professional success and is on a path to independent R01 support. Past and current cobre project leaders have achieved multiple professional milestones in publications, grants, patents, new disease models and research tools, and formation of an idea program/maine state government partnership that allowed MDIBL to obtain $3M in voter-approved state bond funding to expand research infrastructure. Cobre phase III will continue to build the research infrastructure of the davis center by establishing self- sustaining core facilities and funding pilot programs in aging and regeneration research. Essential core services will be provided to cobre graduates, MDIBL investigators, visiting scientists, pilot project awardees, MDIBL course participants from inbre network institutions, and investigators in northeast region (NER) idea states. Pilot project funding and imaging technology access grants will be made available to all investigators in NER idea states. Cobre phase III will greatly enhance the development of the davis center and MDIBL, which in turn will ensure the continued enhancement of the biomedical research environment in maine.

Transactions

Action Obligated Date
Amendment $1,256,464
Amendment $1,265,252
Original award $1,249,777

Subawards

Subrecipient Amount Awarded
Jackson Laboratory Stroke is the leading cause of adult disability in the United States, yet no FDA-approved therapies exist to promote recovery for chronic stroke survivors.… $100,000
University Of Maine System Sarcopenia is an age-related disease that results in progressive declines in muscle mass and function. It often affects a majority of the population over 80… $75,345
Jackson Laboratory This project is led by Dr. Rafiou Agoro at The Jackson Laboratory and will employ novel genetic mouse models to assess the role of the candidate gene in the… $99,975
Mainehealth The goal is to identify optimal red-light conditions for enhancing thermogenesis and to explore the potential synergistic effects of dual expression of bPAC and… $100,000

Quick answers

Who received award P30GM154610?

P30GM154610 was awarded to The Mount Desert Island Biological Laboratory by National Institute of General Medical Sciences (National Institutes of Health) on July 3, 2024.

How much is award P30GM154610 worth?

$3,771,493 has been obligated on P30GM154610.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award